It can cause tumor progression, and other research has proven that IL33 can increase the invasion and migration of glioma cancer cells by up-regulating MMP2 and MMP9 through the ST2_NF-κB signaling pathway [20]. The gene discussed is NFKB1; the disease is neoplasm.